State of Alaska, Department of Revenue - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$823
-13.0%
85,488
-3.9%
0.01%
-9.1%
Q2 2023$946
-1.6%
88,926
-2.7%
0.01%0.0%
Q1 2023$961
-16.5%
91,387
-1.7%
0.01%
-21.4%
Q4 2022$1,151
-99.9%
92,928
+0.7%
0.01%
+7.7%
Q3 2022$956,000
-28.7%
92,295
-20.7%
0.01%
-18.8%
Q2 2022$1,341,000116,3800.02%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders